SCHEMBL618882

SCHEMBL618882

Cc1nc2ncccc2cc1C(=O)NCc1cccc(C(=O)Nc2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.48
SENP1 Q9P0U3 3/20 0.46
HTT P42858 2/20 0.46
ALDH1A1 P00352 2/20 0.46
SENP5 Q96HI0 2/20 0.46
SENP2 Q9HC62 2/20 0.46
HPGD P15428 1/20 0.46
AURKA O14965 1/20 0.46
RPS6KB1 P23443 1/20 0.46
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
EGLN1 Q9GZT9 1/20 0.44
KLKB1 P03952 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
NAMPT P43490 1/20 0.43
NSD2 O96028 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10278163 0.86 EGLN1 (0.57) HTTALDH1A1HPGDLMNASMN1; SMN2
SCHEMBL248260 0.85 ROCK2 (0.46) HTTHPGDSMN1; SMN2EGLN1MEN1
SCHEMBL619376 0.85 LIPG (0.49) HTTALDH1A1LMNASMN1; SMN2EGLN1
SCHEMBL620070 0.83 HTT (0.54) HTTHPGDLMNASMN1; SMN2EGLN1
SCHEMBL617421 0.81 KMT2A (0.55) HTTALDH1A1HPGDRPS6KB1LMNA
SCHEMBL617738 0.81 MAPT (0.52) HTTHPGDLMNASMN1; SMN2EGLN1
SCHEMBL617401 0.81 HTT (0.46) HTTALDH1A1RPS6KB1SMN1; SMN2EGLN1
SCHEMBL619639 0.80 HTT (0.56) HTTALDH1A1HPGDLMNASMN1; SMN2
SCHEMBL617423 0.80 KMT2A (0.62) ALDH1A1HPGDLMNAEGLN1MEN1
SCHEMBL10232805 0.79 HTT (0.45) HTTHPGDMAPK1SMN1; SMN2EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401275-B1 NAPHTHYRIDINE DERIVATIVES HAVING BRONCHODILATING ACTIVITY RESPIRATORIUS AB (SE) 2013-07-24 EP claimed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US claimed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US claimed
EP-2401275-B1 NAPHTHYRIDINE DERIVATIVES HAVING BRONCHODILATING ACTIVITY RESPIRATORIUS AB (SE) 2013-07-24 EP disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS CHRM3, ADRB1, ADRB3 PPARG 722/4885SENP1 3886/4885HTT 4219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.